Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours

Patients treated with tamoxifen (TAM) for primary breast cancer often manifest de novo or acquired resistance, possibly through changes in drug metabolism. Using solid-phase extraction methods and reversed-phase high-performance liquid chromatography separations, levels of TAM and metabolites 4-hydr...

Descripción completa

Detalles Bibliográficos
Autores principales: MacCallum, J, Cummings, J, Dixon, J M, Miller, W R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374506/
https://www.ncbi.nlm.nih.gov/pubmed/10817496
http://dx.doi.org/10.1054/bjoc.2000.1120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374506/
https://www.ncbi.nlm.nih.gov/pubmed/10817496
http://dx.doi.org/10.1054/bjoc.2000.1120

Ejemplares similares